If glycemic control has not been reached after 2 weeks, the dosage should be increased, this can be done until control is reached. However, there is the danger of excessive dosages, as a result, this can lead to hypoglycemia caused by abnormal insulin production. Insulin induction by<unk>  is independent of the glucose levels which only increases the risk of lowering the blood sugar below normal. Moreover, it can lead to weight gain, nausea, skin irritation and, very rarely, photosensitivity. Some patients become susceptible to urinary tract infections, after one incident the likelihood of another increases, therefore it can further lead to an urinary tract disorder. This is caused by metabolite precipitation due to acetylated sulfonamides in the urinary tract.
Glysobuzole
Glybuzole
Amivantamab
Memantine
Rilonacept
Lepra 
Pivagabine
Nusinersen